Last reviewed · How we verify

NCT05425589

Adjustable Strabismus Surgery

Status unknown NA Last updated 21 June 2022
What this trial tests

NA trial testing Adjustable strabismus surgery in Strabismus in 50 participants. Status unknown.

Timeline
1 October 2017
Primary endpoint
1 January 2024
1 October 2024

Quick facts

Lead sponsorFoundation University Islamabad
PhaseNA
StatusStatus unknown
Study typeINTERVENTIONAL
Allocationna
Designsingle group
Maskingnone
Primary purposetreatment
Enrollment50
Start date1 October 2017
Primary completion1 January 2024
Estimated completion1 October 2024
Sites1 location across Pakistan

Drugs / interventions tested

Conditions studied

Sponsor

Foundation University Islamabad

Who can join

Adults 5 to 69, any sex, with Strabismus. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Strabismus, whether congenital or acquired, is a common visual and cosmetic problem, especially for the young. Adjustable suture strabismus surgery is not in vogue in our country. This technique gives the surgeon a second attempt to provide a better outcome for the patients.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of Adjustable strabismus surgery

Trials testing the same drug.

Other recruiting trials for Strabismus

Currently open trials in the same condition.

Other Foundation University Islamabad trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05425589.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing